Complex interplay between the immune system, metabolism, and epigenetic factors in autoimmune liver diseases

[1]  Lei Zhou,et al.  Metabolic heterogeneity caused by HLA-DRB1*04:05 and protective effect of inosine on autoimmune hepatitis , 2022, Frontiers in Immunology.

[2]  K. Kowdley,et al.  Farnesoid X receptor agonist tropifexor attenuates cholestasis in a randomised trial in patients with primary biliary cholangitis , 2022, JHEP reports : innovation in hepatology.

[3]  T. Helleday,et al.  NUDT1 promotes the accumulation and longevity of CD103+ TRM cells in primary biliary cholangitis. , 2022, Journal of hepatology.

[4]  Yin Zhu,et al.  Lactobacillus rhamnosus GG combined with inosine ameliorates alcohol-induced liver injury through regulation of intestinal barrier and Treg/Th1 cells. , 2022, Toxicology and applied pharmacology.

[5]  Nicole M. Chapman,et al.  Metabolic adaptation of lymphocytes in immunity and disease. , 2022, Immunity.

[6]  Bo Li,et al.  MutT Homolog 1 Inhibitor Karonudib Attenuates Autoimmune Hepatitis by Inhibiting DNA Repair in Activated T Cells , 2021, Hepatology communications.

[7]  Miao Zhang,et al.  Activation of AMPKα1 is essential for regulatory T cell function and autoimmune liver disease prevention , 2021, Cellular & Molecular Immunology.

[8]  Tinghong Ye,et al.  Glucose Metabolism Reprogramming of Regulatory T Cells in Concanavalin A-Induced Hepatitis , 2021, Frontiers in Pharmacology.

[9]  P. Trivedi,et al.  Recent advances in clinical practice: epidemiology of autoimmune liver diseases , 2021, Gut.

[10]  Yves Renaudineau,et al.  Altered DNA methylation pattern characterizes the peripheral immune cells of patients with autoimmune hepatitis , 2021, medRxiv.

[11]  A. Müller,et al.  24-Norursodeoxycholic acid reshapes immunometabolism in CD8+ T cells and alleviates hepatic inflammation , 2021, Journal of hepatology.

[12]  Wei Chen,et al.  Protective Effects of Microbiome-Derived Inosine on Lipopolysaccharide-Induced Acute Liver Damage and Inflammation in Mice via Mediating the TLR4/NF-κB Pathway. , 2021, Journal of agricultural and food chemistry.

[13]  S. Forbes,et al.  Liver regeneration and inflammation: from fundamental science to clinical applications , 2021, Nature Reviews Molecular Cell Biology.

[14]  Huafeng Zhang,et al.  Metabolic reprogramming and epigenetic modifications on the path to cancer , 2021, Protein & Cell.

[15]  D. Vergani,et al.  Human Leukocyte Antigen Profile Predicts Severity of Autoimmune Liver Disease in Children of European Ancestry , 2021, Hepatology.

[16]  H. Young,et al.  IFNγ Is a Key Link between Obesity and Th1-Mediated AutoImmune Diseases , 2020, International journal of molecular sciences.

[17]  J. Chiang,et al.  Bile acid-based therapies for non-alcoholic steatohepatitis and alcoholic liver disease. , 2020, Hepatobiliary surgery and nutrition.

[18]  Cuisong Zhou,et al.  Demethyleneberberine attenuates concanavalin A-induced autoimmune hepatitis in mice through inhibition of NF-κB and MAPK signaling. , 2020, International immunopharmacology.

[19]  Y. Saeys,et al.  Stellate Cells, Hepatocytes, and Endothelial Cells Imprint the Kupffer Cell Identity on Monocytes Colonizing the Liver Macrophage Niche , 2019, Immunity.

[20]  D. Adams,et al.  Liver homing of clinical grade Tregs after therapeutic infusion in patients with autoimmune hepatitis , 2019, JHEP reports.

[21]  Jiang Chen,et al.  Foxp3+ Treg Cells Are Associated with Pathological Process of Autoimmune Hepatitis by Activating Methylation Modification in Autoimmune Hepatitis Patients , 2019, Medical science monitor : international medical journal of experimental and clinical research.

[22]  Andrew R. Bassett,et al.  GPR35 promotes glycolysis, proliferation, and oncogenic signaling by engaging with the sodium potassium pump , 2019, Science Signaling.

[23]  P. Kamath,et al.  Burden of liver diseases in the world. , 2019, Journal of hepatology.

[24]  A. Floreani,et al.  Etiopathogenesis of autoimmune hepatitis. , 2018, Journal of autoimmunity.

[25]  A. Montano‐Loza,et al.  Severe vitamin D deficiency is a prognostic biomarker in autoimmune hepatitis , 2018, Alimentary pharmacology & therapeutics.

[26]  M. Fu,et al.  Inhibition of microRNA-155 attenuates concanavalin-A-induced autoimmune hepatitis by regulating Treg/Th17 cell differentiation. , 2018, Canadian journal of physiology and pharmacology.

[27]  P. Kubes,et al.  Immune Responses in the Liver. , 2018, Annual review of immunology.

[28]  T. Liwinski,et al.  Autoantibodies in Autoimmune Liver Disease—Clinical and Diagnostic Relevance , 2018, Front. Immunol..

[29]  G. Veres,et al.  Loss of tolerance to gut immunity protein, glycoprotein 2 (GP2) is associated with progressive disease course in primary sclerosing cholangitis , 2018, Scientific Reports.

[30]  Bangmao Wang,et al.  The Effects of Berberine on Concanavalin A-Induced Autoimmune Hepatitis (AIH) in Mice and the Adenosine 5′-Monophosphate (AMP)-Activated Protein Kinase (AMPK) Pathway , 2017, Medical science monitor : international medical journal of experimental and clinical research.

[31]  P. McNamara,et al.  Discovery of Tropifexor (LJN452), a Highly Potent Non-bile Acid FXR Agonist for the Treatment of Cholestatic Liver Diseases and Nonalcoholic Steatohepatitis (NASH). , 2017, Journal of medicinal chemistry.

[32]  T. Karlsen,et al.  Primary sclerosing cholangitis - a comprehensive review. , 2017, Journal of hepatology.

[33]  David K. Finlay,et al.  Glucose represses dendritic cell-induced T cell responses , 2017, Nature Communications.

[34]  Michael M. Henry,et al.  Manipulating DNA damage-response signaling for the treatment of immune-mediated diseases , 2017, Proceedings of the National Academy of Sciences.

[35]  Yun Lu,et al.  Glucocorticoid receptor promotes the function of myeloid-derived suppressor cells by suppressing HIF1α-dependent glycolysis , 2017, Cellular & Molecular Immunology.

[36]  J. Rathmell,et al.  A guide to immunometabolism for immunologists , 2016, Nature Reviews Immunology.

[37]  K. Boberg,et al.  Serum microRNAs as novel biomarkers for primary sclerosing cholangitis and cholangiocarcinoma , 2016, Clinical and experimental immunology.

[38]  R. Mostoslavsky,et al.  Interplay between Metabolism and Epigenetics: A Nuclear Adaptation to Environmental Changes. , 2016, Molecular cell.

[39]  I. Mackay,et al.  Evolving Trends in Female to Male Incidence and Male Mortality of Primary Biliary Cholangitis , 2016, Scientific Reports.

[40]  G. Tiegs,et al.  Modulation of liver tolerance by conventional and nonconventional antigen-presenting cells and regulatory immune cells , 2016, Cellular & Molecular Immunology.

[41]  T. Thum,et al.  Circulating miR-21 and miR-29a as Markers of Disease Severity and Etiology in Cholestatic Pediatric Liver Disease , 2016, Journal of clinical medicine.

[42]  A. Margolles,et al.  Interaction of Intestinal Microorganisms with the Human Host in the Framework of Autoimmune Diseases , 2015, Front. Immunol..

[43]  K. Migita,et al.  Circulating microRNA Profiles in Patients with Type-1 Autoimmune Hepatitis , 2015, PloS one.

[44]  R. Coppel,et al.  The modulation of co-stimulatory molecules by circulating exosomes in primary biliary cirrhosis , 2015, Cellular and Molecular Immunology.

[45]  D. Adams,et al.  DNA methylation profiling of the X chromosome reveals an aberrant demethylation on CXCR3 promoter in primary biliary cirrhosis , 2015, Clinical Epigenetics.

[46]  K. Lindor,et al.  Efficacy of obeticholic acid in patients with primary biliary cirrhosis and inadequate response to ursodeoxycholic acid. , 2015, Gastroenterology.

[47]  D. Vergani,et al.  Regulatory T cells: Mechanisms of suppression and impairment in autoimmune liver disease , 2015, IUBMB life.

[48]  Jiyuan Zhang,et al.  CXCR5+ CD4+ T follicular helper cells participate in the pathogenesis of primary biliary cirrhosis , 2015, Hepatology.

[49]  Y. Shoenfeld,et al.  Vitamin D in primary biliary cirrhosis, a plausible marker of advanced disease , 2014, Immunologic Research.

[50]  A. Tanoğlu,et al.  Oxidative Stress Might Play a Role in Low Serum Vitamin D Associated Liver Fibrosis Among Patients with Autoimmune Hepatitis , 2015, Digestive Diseases and Sciences.

[51]  J. Baier,et al.  Mechanisms of autoimmune liver disease. , 2014, Discovery medicine.

[52]  Mohsen Naghavi,et al.  Liver cirrhosis mortality in 187 countries between 1980 and 2010: a systematic analysis , 2014, BMC Medicine.

[53]  S. Sabbioni,et al.  MicroRNAs in liver cancer: a model for investigating pathogenesis and novel therapeutic approaches , 2014, Cell Death and Differentiation.

[54]  D. Bogdanos,et al.  Low Serum Vitamin D Levels Are Associated with Severe Histological Features and Poor Response to Therapy in Patients with Autoimmune Hepatitis , 2014, Digestive Diseases and Sciences.

[55]  M. Ota,et al.  Human Leukocyte Antigen Class II Haplotypes Affect Clinical Characteristics and Progression of Type 1 Autoimmune Hepatitis in Japan , 2014, PloS one.

[56]  M. Seldin,et al.  Genome-Wide Analysis of DNA Methylation, Copy Number Variation, and Gene Expression in Monozygotic Twins Discordant for Primary Biliary Cirrhosis , 2014, Front. Immunol..

[57]  C. Couto,et al.  Antismooth muscle and antiactin antibodies are indirect markers of histological and biochemical activity of autoimmune hepatitis , 2014, Hepatology.

[58]  A. van den Berg,et al.  Comprehensive analysis of miRNA expression in T-cell subsets of rheumatoid arthritis patients reveals defined signatures of naive and memory Tregs , 2014, Genes and Immunity.

[59]  K. Okazaki,et al.  Nationwide survey for primary sclerosing cholangitis and IgG4‐related sclerosing cholangitis in Japan , 2014, Journal of hepato-biliary-pancreatic sciences.

[60]  D. Bogdanos,et al.  Vitamin D in autoimmune liver disease. , 2013, Clinics and research in hepatology and gastroenterology.

[61]  L. Nguyễn,et al.  The Role of Vitamin D in Autoimmune Hepatitis , 2013, Journal of clinical medicine research.

[62]  D. Vergani,et al.  Liver transplantation and autoimmune liver diseases , 2013, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[63]  C. Gieger,et al.  Genome‐wide association analysis in Primary sclerosing cholangitis and ulcerative colitis identifies risk loci at GPR35 and TCF4 , 2013, Hepatology.

[64]  Terry M. Therneau,et al.  Underestimation of liver-related mortality in the United States. , 2013, Gastroenterology.

[65]  A. Bergquist,et al.  Primary sclerosing cholangitis is associated with autoreactive IgA antibodies against biliary epithelial cells , 2013, Scandinavian journal of gastroenterology.

[66]  J. Qian,et al.  MiR-122 modulates type I interferon expression through blocking suppressor of cytokine signaling 1. , 2013, The international journal of biochemistry & cell biology.

[67]  M. Gershwin,et al.  Epigenetic considerations and the clinical reevaluation of the overlap syndrome between primary biliary cirrhosis and autoimmune hepatitis. , 2013, Journal of autoimmunity.

[68]  Garnet Navarro,et al.  miR-451 Regulates Dendritic Cell Cytokine Responses to Influenza Infection , 2012, The Journal of Immunology.

[69]  R. Jalan,et al.  Serum autotaxin is increased in pruritus of cholestasis, but not of other origin and responds to therapeutic interventions , 2015 .

[70]  A. Czaja.  Autoimmune hepatitis: focusing on treatments other than steroids. , 2012, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.

[71]  N. LaRusso,et al.  Up‐regulation of microRNA 506 leads to decreased Cl−/HCO3− anion exchanger 2 expression in biliary epithelium of patients with primary biliary cirrhosis , 2012, Hepatology.

[72]  D. Riches,et al.  Vitamin D Inhibits Monocyte/Macrophage Proinflammatory Cytokine Production by Targeting MAPK Phosphatase-1 , 2012, The Journal of Immunology.

[73]  Chao Sun,et al.  p38 MAPK regulates calcium signal-mediated lipid accumulation through changing VDR expression in primary preadipocytes of mice , 2012, Molecular Biology Reports.

[74]  R. Coppel,et al.  AUTOIMMUNE, CHOLESTATIC AND BILIARY DISEASE Immunoglobulin M Levels Inversely Correlate with CD40 Ligand Promoter Methylation in Patients with Primary Biliary Cirrhosis , 2011 .

[75]  T. Therneau,et al.  Utility of serum immunoglobulin G4 in distinguishing immunoglobulin G4‐associated cholangitis from cholangiocarcinoma , 2011, Hepatology.

[76]  J. G. Cripps,et al.  MDSC in autoimmunity. , 2011, International immunopharmacology.

[77]  Jue Wei,et al.  Interleukin-17 Contributes to the Pathogenesis of Autoimmune Hepatitis through Inducing Hepatic Interleukin-6 Expression , 2011, PloS one.

[78]  Nam-Ho Kim,et al.  Mitogen-Activated Protein Kinases and Reactive Oxygen Species: How Can ROS Activate MAPK Pathways? , 2011, Journal of signal transduction.

[79]  R. Xia,et al.  β-Arrestin 1 Modulates Functions of Autoimmune T Cells from Primary Biliary Cirrhosis Patients , 2011, Journal of Clinical Immunology.

[80]  L. Zammataro,et al.  Epigenetic investigation of variably X chromosome inactivated genes in monozygotic female twins discordant for primary biliary cirrhosis , 2011, Epigenetics.

[81]  Todd Davidson,et al.  Generation of Pathogenic Th17 Cells in the Absence of TGF-β Signaling , 2010, Nature.

[82]  M. Esteller,et al.  Epigenetic modifications and human disease , 2010, Nature Biotechnology.

[83]  C. Liu,et al.  Preventive effects of 1,25-(OH)2VD3 against ConA-induced mouse hepatitis through promoting vitamin D receptor gene expression , 2010, Acta Pharmacologica Sinica.

[84]  Keshava Rajagopal,et al.  Teaching old receptors new tricks: biasing seven-transmembrane receptors , 2010, Nature Reviews Drug Discovery.

[85]  Pietro Invernizzi,et al.  Geoepidemiology of autoimmune liver diseases. , 2010, Journal of autoimmunity.

[86]  A. Lohse,et al.  Immune tolerance: what is unique about the liver. , 2010, Journal of autoimmunity.

[87]  D. Vergani,et al.  Aetiopathogenesis of autoimmune hepatitis. , 2010, Journal of autoimmunity.

[88]  Chuanshu Huang,et al.  Gadd45 Proteins as Critical Signal Transducers Linking NF-κB to MAPK Cascades , 2009 .

[89]  Ana Lleo,et al.  Primary biliary cirrhosis is associated with altered hepatic microRNA expression. , 2009, Journal of autoimmunity.

[90]  B. Viollet,et al.  AMP‐activated protein kinase in the regulation of hepatic energy metabolism: from physiology to therapeutic perspectives , 2009, Acta physiologica.

[91]  M. Trauner,et al.  When lightning strikes twice: the plot thickens for a dual role of the anion exchanger 2 (AE2/SLC4A2) in the pathogenesis and treatment of primary biliary cirrhosis. , 2009, Journal of hepatology.

[92]  Y. Nakanuma,et al.  Telomere shortening in the damaged small bile ducts in primary biliary cirrhosis reflects ongoing cellular senescence , 2008, Hepatology.

[93]  U. Beuers,et al.  Overlap syndromes among autoimmune liver diseases. , 2008, World journal of gastroenterology.

[94]  F. Lund.  Cytokine-producing B lymphocytes-key regulators of immunity. , 2008, Current opinion in immunology.

[95]  J. Prieto,et al.  Ae2a,b-deficient mice develop antimitochondrial antibodies and other features resembling primary biliary cirrhosis. , 2008, Gastroenterology.

[96]  Yi-tao Jia,et al.  Inhibition of p38 mitogen-activated protein kinase attenuates experimental autoimmune hepatitis: involvement of nuclear factor kappa B. , 2007, World journal of gastroenterology.

[97]  C. Selmi,et al.  Preferential X chromosome loss but random inactivation characterize primary biliary cirrhosis , 2007, Hepatology.

[98]  E. Björnsson,et al.  Immunoglobulin G4 associated cholangitis: Description of an emerging clinical entity based on review of the literature , 2007, Hepatology.

[99]  L. Luttrell,et al.  Beta-arrestins 1 and 2 differentially regulate LPS-induced signaling and pro-inflammatory gene expression. , 2007, Molecular immunology.

[100]  M. Washington.  Autoimmune liver disease: overlap and outliers , 2007, Modern Pathology.

[101]  Roger Williams.  Global challenges in liver disease , 2006, Hepatology.

[102]  Y. Ueno,et al.  B cells and autoimmune liver diseases. , 2006, Autoimmunity reviews.

[103]  Min Zhang,et al.  A Nuclear Function of β-Arrestin1 in GPCR Signaling: Regulation of Histone Acetylation and Gene Transcription , 2005, Cell.

[104]  K. Tsuneyama,et al.  IgG4-related Sclerosing Cholangitis With and Without Hepatic Inflammatory Pseudotumor, and Sclerosing Pancreatitis-associated Sclerosing Cholangitis: Do They Belong to a Spectrum of Sclerosing Pancreatitis? , 2004, The American journal of surgical pathology.

[105]  R. Gish,et al.  Primary biliary cirrhosis in monozygotic and dizygotic twins: genetics, epigenetics, and environment. , 2004, Gastroenterology.

[106]  D. Vergani,et al.  Impairment of CD4(+)CD25(+) regulatory T-cells in autoimmune liver disease. , 2004, Journal of hepatology.

[107]  P. Yaqoob.  Fatty acids as gatekeepers of immune cell regulation. , 2003, Trends in immunology.

[108]  K. Lindor,et al.  Primary biliary cirrhosis , 2003, The Lancet.

[109]  John C. Lee,et al.  Restraint of Proinflammatory Cytokine Biosynthesis by Mitogen-Activated Protein Kinase Phosphatase-1 in Lipopolysaccharide-Stimulated Macrophages , 2002, The Journal of Immunology.

[110]  M. Manns,et al.  Genetic association of vitamin D receptor polymorphisms with primary biliary cirrhosis and autoimmune hepatitis , 2002, Hepatology.

[111]  I. Bernard,et al.  Cellular and genetic factors involved in the difference between Brown Norway and Lewis rats to develop respectively type‐2 and type‐1 immune‐mediated diseases , 2001, Immunological reviews.

[112]  R. Chapman,et al.  A preliminary trial of high-dose ursodeoxycholic acid in primary sclerosing cholangitis. , 2001, Gastroenterology.

[113]  D. Vergani,et al.  Virus, liver and autoimmunity. , 2000, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[114]  I. Zosin,et al.  The pattern of a T(H)1 cytokine in autoimmune thyroiditis. , 2000, Immunology letters.

[115]  Shelly C. Lu,et al.  Expression of Bcl-2 increases intracellular glutathione by inhibiting methionine-dependent GSH efflux. , 1998, Biochemical and biophysical research communications.

[116]  Y. Nakanuma,et al.  Enhanced apoptosis relates to bile duct loss in primary biliary cirrhosis , 1997, Hepatology.

[117]  Y. Tsujimoto,et al.  Bcl-2 and Bcl-xL block apoptosis as well as necrosis: possible involvement of common mediators in apoptotic and necrotic signal transduction pathways. , 1997, Leukemia.

[118]  P. Gaulard,et al.  Immunohistochemical detection of bcl-2 protein in normal and pathological human liver. , 1994, The American journal of pathology.

[119]  Z. Oltvai,et al.  Bcl-2 functions in an antioxidant pathway to prevent apoptosis , 1993, Cell.

[120]  J. Prieto,et al.  Abnormal expression of anion exchanger genes in primary biliary cirrhosis. , 1993, Gastroenterology.

[121]  M. Rowley,et al.  Differing epitope selection of experimentally-induced and natural antibodies to a disease-specific autoantigen, the E2 subunit of pyruvate dehydrogenase complex (PDC-E2). , 1992, International immunology.

[122]  R. Isaacs,et al.  Control of DNA polymerase‐α activity in regenerating rat liver by calcium and 1α,25(OH)2D3 , 1989 .

[123]  U. Spengler,et al.  Differential expression of MHC class II subregion products on bile duct epithelial cells and hepatocytes in patients with primary biliary cirrhosis , 1988, Hepatology.

[124]  V. Barnaba,et al.  Expression of class I and class II major histocompatibility complex antigens on human hepatocytes , 1988, Hepatology.

[125]  W W Lautt,et al.  Conceptual review of the hepatic vascular bed , 1987, Hepatology.

[126]  D. Baran,et al.  1,25 Dihydroxyvitamin D increases hepatocyte cytosolic calcium levels. A potential regulator of vitamin D-25-hydroxylase. , 1986, The Journal of clinical investigation.

[127]  D. Doherty.  Immunity, tolerance and autoimmunity in the liver: A comprehensive review. , 2016, Journal of autoimmunity.

[128]  A. Lohse,et al.  Unmet clinical need in autoimmune liver diseases. , 2015, Journal of hepatology.

[129]  M. Trauner,et al.  Bile acid receptors as targets for drug development , 2014, Nature Reviews Gastroenterology &Hepatology.

[130]  J. Neuberger,et al.  Autoimmune liver disease, autoimmunity and liver transplantation. , 2014, Journal of hepatology.

[131]  M. Bloomston,et al.  Liver anatomy. , 2010, The Surgical clinics of North America.

[132]  Peter A. Jones,et al.  Epigenetics in cancer. , 2010, Carcinogenesis.

[133]  G. Hessel,et al.  Nutritional status of patients with biliary atresia and autoimmune hepatitis related to serum levels of vitamins A, D and E. , 2009, Arquivos de gastroenterologia.

[134]  H. Lee,et al.  Susceptibility to type 1 autoimmune hepatitis is associated with shared amino acid sequences at positions 70-74 of the HLA-DRB1 molecule. , 2008, Journal of hepatology.

[135]  B. Spellberg,et al.  Type 1/Type 2 immunity in infectious diseases. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[136]  G. Gores,et al.  Nitric oxide-mediated inhibition of DNA repair potentiates oxidative DNA damage in cholangiocytes. , 2001, Gastroenterology.

[137]  D. Sasse,et al.  Liver architecture. , 1992, Enzyme.